UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Strategic Advisors LLC

Strategic Advisors LLC reduced its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 23.3% in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 6,236 shares of the healthcare conglomerate’s stock after selling 1,897 shares during the period. Strategic Advisors LLC’s holdings in UnitedHealth Group were worth $3,085,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds have also recently modified their holdings of UNH. Maryland State Retirement & Pension System raised its stake in UnitedHealth Group by 0.6% in the first quarter. Maryland State Retirement & Pension System now owns 72,689 shares of the healthcare conglomerate’s stock valued at $35,126,000 after buying an additional 469 shares in the last quarter. Kesler Norman & Wride LLC increased its stake in UnitedHealth Group by 16.3% in the first quarter. Kesler Norman & Wride LLC now owns 19,623 shares of the healthcare conglomerate’s stock valued at $9,709,000 after purchasing an additional 2,755 shares during the last quarter. FORVIS Wealth Advisors LLC boosted its holdings in shares of UnitedHealth Group by 8.9% in the 1st quarter. FORVIS Wealth Advisors LLC now owns 3,385 shares of the healthcare conglomerate’s stock valued at $1,675,000 after buying an additional 277 shares in the last quarter. GenTrust LLC lifted its position in UnitedHealth Group by 14.7% in the first quarter. GenTrust LLC now owns 1,320 shares of the healthcare conglomerate’s stock valued at $653,000 after acquiring an additional 169 shares during the last quarter. Finally, Veracity Capital LLC increased its position in shares of UnitedHealth Group by 1.5% during the first quarter. Veracity Capital LLC now owns 1,335 shares of the healthcare conglomerate’s stock worth $660,000 after purchasing an additional 20 shares in the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts have issued reports on the stock. Piper Sandler raised their price objective on shares of UnitedHealth Group from $566.00 to $571.00 and gave the stock an “overweight” rating in a research report on Wednesday, April 17th. Barclays increased their price objective on UnitedHealth Group from $534.00 to $560.00 and gave the stock an “overweight” rating in a research report on Wednesday, April 17th. Robert W. Baird assumed coverage on UnitedHealth Group in a report on Thursday, May 30th. They set an “outperform” rating and a $597.00 price target for the company. StockNews.com downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Friday, June 28th. Finally, Bank of America reiterated a “buy” rating and issued a $675.00 price target on shares of UnitedHealth Group in a report on Thursday, March 7th. Three research analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $579.74.

UnitedHealth Group Stock Performance

NYSE:UNH traded down $4.62 during midday trading on Friday, reaching $485.27. 631,253 shares of the company traded hands, compared to its average volume of 4,248,694. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $554.70. The firm has a market capitalization of $446.64 billion, a price-to-earnings ratio of 29.94, a price-to-earnings-growth ratio of 1.44 and a beta of 0.60. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.85 and a quick ratio of 0.85. The company has a fifty day moving average price of $498.61 and a 200 day moving average price of $500.96.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share for the quarter, beating the consensus estimate of $6.63 by $0.28. The firm had revenue of $99.80 billion for the quarter, compared to the consensus estimate of $99.23 billion. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The firm’s revenue for the quarter was up 8.6% on a year-over-year basis. During the same quarter in the previous year, the business earned $6.26 EPS. On average, analysts expect that UnitedHealth Group Incorporated will post 27.55 EPS for the current fiscal year.

UnitedHealth Group Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, June 25th. Investors of record on Monday, June 17th were issued a dividend of $2.10 per share. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $1.88. This represents a $8.40 dividend on an annualized basis and a yield of 1.73%. The ex-dividend date of this dividend was Monday, June 17th. UnitedHealth Group’s payout ratio is presently 51.34%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.